Keyphrases
Overexpression
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
C-kit
100%
Multiple Myeloma
100%
CD117
100%
Tyrosine Kinase Inhibitor
18%
β-cell Dysfunction
18%
Signal Transduction
9%
Immunohistochemistry
9%
Solid Tumors
9%
Chronic Myeloid Leukemia
9%
Oncogene
9%
Small Sample Size
9%
Median Survival
9%
Poor Prognosis
9%
Oncoprotein
9%
Conventional Therapy
9%
Plasma Cell Dyscrasia
9%
CD117 Expression
9%
Pathological Specimen
9%
Target-directed
9%
Immunohistochemical Tests
9%
Imatinib Mesylate
9%
Biochemistry, Genetics and Molecular Biology
CD117
100%
B Cell
40%
Tyrosine Kinase Inhibitor
40%
Signal Transduction
20%
Sample Size
20%
Oncogene
20%
Plasma Cell
20%
Retrospective Study
20%
Mesylate
20%
Imatinib
20%
Neuroscience
CD117
100%
Tyrosine Kinase Inhibitor
40%
Immunohistochemistry
40%
B Cell
40%
Cell Signaling
20%
Oncogene
20%
Oncoprotein
20%
Plasma Cell
20%
Imatinib
20%
Medicine and Dentistry
Multiple Myeloma
100%
Disease
25%
Immunohistochemistry
25%
Tyrosine-Kinase Inhibitor
25%
B Cell
25%
Signal Transduction
12%
Solid Malignant Neoplasm
12%
Retrospective Study
12%
Chronic Myelogenous Leukemia
12%
Oncogene
12%
Oncoprotein
12%
Plasma Cell Dyscrasia
12%
Imatinib
12%